| 25 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
8.4 |
10mg |
12.0mg |
+20.3% |
98.61% |
Lab C |
| 25 May 2026 |
Estradiol Cypionate |
7.5 |
300mg/ml |
366.8mg/ml |
+22.3% |
98.88% |
Lab F |
| 25 May 2026 |
Methylstenbolone |
7.5 |
20mg |
22.2mg |
+10.9% |
98.48% |
Lab B |
| 25 May 2026 |
MOTS-C |
6.6 |
30mg |
31.3mg |
+4.2% |
95.12% |
Lab A |
| 25 May 2026 |
SNAP-8 |
6.9 |
20mg |
24.1mg |
+20.3% |
99.73% |
Lab A |
| 25 May 2026 |
Tirzepatide 30mg Pen Kit |
6.7 |
20mg |
23.6mg |
+18.2% |
95.61% |
Lab C |
| 24 May 2026 |
17a-Methyl-1-Testosterone |
5.4 |
25mg |
29.9mg |
+19.7% |
96.54% |
Lab A |
| 24 May 2026 |
Clenbuterol |
5.0 |
20mg |
19.4mg |
-2.9% |
98.43% |
Lab G |
| 24 May 2026 |
HCG |
5.5 |
50mg |
48.3mg |
-3.3% |
97.18% |
Lab B |
| 24 May 2026 |
Proviron (Mesterolone) |
7.9 |
10mg |
11.8mg |
+18.0% |
99.64% |
Lab C |
| 24 May 2026 |
BPC-157 |
6.6 |
10mg |
12.6mglabel |
14.7mg |
+17.1% |
BPC1001212026-18 |
| 24 May 2026 |
Tirzepatide |
4.4 |
30mg |
(no batch claim) |
53.4mg |
+78.0% |
NXP-2P3002072026-01 |
| 24 May 2026 |
Arimidex (Anastrozole) |
5.8 |
10mg |
10.7mg |
+7.3% |
95.83% |
Lab D |
| 24 May 2026 |
BPC-157 Arg Oral |
9.9 |
100mg |
109.7mg |
+9.7% |
96.57% |
Lab C |
| 24 May 2026 |
Dianabol Raw |
6.9 |
10g |
11.9g |
+19.1% |
96.97% |
Lab B |
| 24 May 2026 |
Minoxidil Oral |
9.0 |
25mg |
30.1mg |
+20.4% |
98.75% |
Lab F |
| 24 May 2026 |
PE 22-28 |
5.0 |
50mg |
62.0mg |
+24.0% |
96.62% |
Lab F |
| 24 May 2026 |
PTD-DBM |
5.3 |
10mg |
10.2mg |
+1.7% |
95.51% |
Lab D |
| 24 May 2026 |
S-23 Raw |
6.6 |
100g |
89.6g |
-10.4% |
96.74% |
Lab D |
| 24 May 2026 |
Trenbolone Acetate Raw |
4.9 |
500g |
567.4g |
+13.5% |
95.82% |
Lab A |
| 24 May 2026 |
Trenbolone Acetate Raw |
8.0 |
1g |
1.0g |
-1.8% |
99.12% |
Lab G |
| 24 May 2026 |
Retatrutide |
8.8 |
12mg |
(no batch claim) |
12.9mg |
+7.5% |
NXP-3P1201092026-01 |
| 24 May 2026 |
Retatrutide |
9.3 |
24mg |
(no batch claim) |
25.7mg |
+7.1% |
NXP-3P2401262026-13 |
| 24 May 2026 |
Retatrutide |
8.4 |
24mg |
14.1mglabel |
13.6mg |
-3.2% |
NXP-3P1201092026-01 |
| 24 May 2026 |
Dermorphin |
6.7 |
5mg |
4.9mg |
-2.3% |
98.06% |
Lab A |
| 24 May 2026 |
DSIP |
8.3 |
5mg |
5.7mg |
+14.0% |
98.76% |
Lab B |
| 24 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
7.5 |
30mg |
35.9mg |
+19.6% |
95.66% |
Lab F |
| 24 May 2026 |
Methylstenbolone |
7.7 |
100mg |
100.1mg |
+0.1% |
99.43% |
Lab F |
| 24 May 2026 |
Methylstenbolone |
6.2 |
50mg |
45.9mg |
-8.2% |
98.46% |
Lab G |
| 24 May 2026 |
Minoxidil Oral |
7.7 |
20mg |
18.5mg |
-7.3% |
97.78% |
Lab A |
| 24 May 2026 |
Ostarine (MK-2866) |
8.7 |
100mg |
106.9mg |
+6.9% |
96.59% |
Lab F |
| 24 May 2026 |
P21 |
7.1 |
50mg |
58.4mg |
+16.7% |
96.54% |
Lab D |
| 24 May 2026 |
SNAP-8 |
7.0 |
5mg |
4.4mg |
-12.4% |
97.39% |
Lab B |
| 24 May 2026 |
SNAP-8 |
5.5 |
15mg |
13.7mg |
-8.9% |
98.93% |
Lab A |
| 24 May 2026 |
Trenbolone Acetate Raw |
4.9 |
1g |
0.9g |
-9.0% |
99.27% |
Lab E |
| 24 May 2026 |
Tesamorelin |
8.2 |
10mg |
11.9mglabel |
11.7mg |
-1.5% |
TES1001172026-16 |
| 24 May 2026 |
Tirzepatide |
9.3 |
60mg |
69.9mglabel |
65mg |
-7.0% |
NXP-2p6001152026-01 |
| 24 May 2026 |
BAM15 |
8.5 |
25mg |
24.5mg |
-2.0% |
95.93% |
Lab F |
| 24 May 2026 |
BPC-157 Arg Oral |
7.4 |
100mg |
88.6mg |
-11.4% |
99.91% |
Lab A |
| 24 May 2026 |
BPC-157 Arg Oral |
7.0 |
50mg |
54.0mg |
+8.1% |
95.02% |
Lab F |
| 24 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
5.6 |
5mg |
5.2mg |
+4.3% |
97.60% |
Lab F |
| 24 May 2026 |
Clenbuterol |
7.1 |
20mg |
22.4mg |
+12.0% |
99.08% |
Lab D |
| 24 May 2026 |
Methylstenbolone |
7.3 |
20mg |
21.8mg |
+9.2% |
97.14% |
Lab C |
| 24 May 2026 |
MOTS-C |
5.4 |
5mg |
4.6mg |
-8.1% |
99.07% |
Lab C |
| 24 May 2026 |
MOTS-C |
7.1 |
5mg |
6.0mg |
+19.6% |
95.06% |
Lab D |
| 24 May 2026 |
P21 |
9.6 |
15mg |
16.1mg |
+7.0% |
97.18% |
Lab G |
| 24 May 2026 |
P21 |
7.7 |
15mg |
13.1mg |
-12.7% |
98.22% |
Lab B |
| 24 May 2026 |
PEG MGF |
4.8 |
2mg |
2.0mg |
+0.0% |
99.47% |
Lab C |
| 24 May 2026 |
Trenbolone Acetate Raw |
7.0 |
500g |
464.8g |
-7.0% |
98.62% |
Lab A |
| 24 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.6 |
50mg |
43.2mg |
-13.6% |
97.40% |
Lab C |
| 24 May 2026 |
LGD-4033 (Ligandrol) Raw |
8.7 |
100g |
116.1g |
+16.1% |
96.80% |
Lab G |
| 24 May 2026 |
Lipo-B 216mg |
7.8 |
300mg/ml |
281.4mg/ml |
-6.2% |
99.88% |
Lab G |
| 24 May 2026 |
Methylstenbolone |
8.1 |
50mg |
46.2mg |
-7.6% |
99.46% |
Lab E |
| 24 May 2026 |
P21 |
8.8 |
5mg |
4.7mg |
-5.0% |
98.20% |
Lab A |
| 24 May 2026 |
PEG MGF |
7.6 |
50mg |
56.9mg |
+13.9% |
98.98% |
Lab A |
| 24 May 2026 |
Proviron (Mesterolone) |
8.2 |
25mg |
23.9mg |
-4.5% |
96.20% |
Lab D |
| 24 May 2026 |
SNAP-8 |
8.4 |
50mg |
46.7mg |
-6.6% |
99.43% |
Lab D |
| 23 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
6.9 |
10mg |
9.0mg |
-9.6% |
99.92% |
Lab A |
| 23 May 2026 |
Clenbuterol |
7.8 |
20mg |
19.2mg |
-3.8% |
95.42% |
Lab A |
| 23 May 2026 |
DSIP |
5.5 |
2mg |
2.5mg |
+23.6% |
95.64% |
Lab E |
| 23 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.2 |
2mg |
2.4mg |
+20.0% |
98.42% |
Lab A |
| 23 May 2026 |
Ostarine (MK-2866) |
6.4 |
50mg |
52.9mg |
+5.8% |
99.23% |
Lab F |
| 23 May 2026 |
PE 22-28 |
6.6 |
50mg |
43.8mg |
-12.4% |
95.68% |
Lab C |
| 23 May 2026 |
Proviron (Mesterolone) |
7.6 |
10mg |
10.5mg |
+5.5% |
99.11% |
Lab G |
| 23 May 2026 |
SNAP-8 |
8.2 |
10mg |
8.9mg |
-10.8% |
95.83% |
Lab C |
| 23 May 2026 |
T3 (Liothyronine) |
5.7 |
100mg |
88.4mg |
-11.6% |
98.63% |
Lab B |
| 23 May 2026 |
T3 (Liothyronine) |
5.5 |
20mg |
18.7mg |
-6.4% |
99.09% |
Lab A |
| 23 May 2026 |
17a-Methyl-1-Testosterone |
5.8 |
10mg |
8.9mg |
-10.6% |
98.67% |
Lab B |
| 23 May 2026 |
Anadrol Oil |
4.0 |
200mg/ml |
198.3mg/ml |
-0.8% |
96.21% |
Lab C |
| 23 May 2026 |
BPC-157 Arg Oral |
5.8 |
100mg |
95.3mg |
-4.7% |
95.90% |
Lab A |
| 23 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
4.6 |
2mg |
2.4mg |
+17.9% |
99.47% |
Lab B |
| 23 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.3 |
20mg |
17.5mg |
-12.4% |
96.75% |
Lab A |
| 23 May 2026 |
HCG |
6.0 |
10mg |
8.5mg |
-14.7% |
98.32% |
Lab D |
| 21 May 2026 |
17a-Methyl-1-Testosterone |
5.5 |
25mg |
25.6mg |
+2.6% |
96.69% |
Lab D |
| 21 May 2026 |
Anadrol Oil |
4.0 |
250mg/ml |
244.6mg/ml |
-2.2% |
99.87% |
Lab G |
| 21 May 2026 |
BPC-157 Arg Oral |
8.3 |
50mg |
52.8mg |
+5.6% |
95.30% |
Lab A |
| 21 May 2026 |
Dermorphin |
7.3 |
2mg |
2.0mg |
+1.4% |
97.92% |
Lab A |
| 21 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.1 |
15mg |
16.4mg |
+9.3% |
97.13% |
Lab D |
| 21 May 2026 |
HCG |
7.0 |
20mg |
23.4mg |
+17.1% |
98.82% |
Lab E |
| 21 May 2026 |
Lipo-B 216mg |
7.2 |
200mg/ml |
239.4mg/ml |
+19.7% |
97.37% |
Lab A |
| 21 May 2026 |
Lipo-B 216mg |
6.2 |
100mg/ml |
98.9mg/ml |
-1.1% |
95.55% |
Lab A |
| 21 May 2026 |
Lipo-B 216mg |
7.8 |
200mg/ml |
210.0mg/ml |
+5.0% |
99.99% |
Lab F |
| 21 May 2026 |
MOTS-C |
5.9 |
30mg |
30.6mg |
+1.8% |
96.05% |
Lab G |
| 21 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
8.1 |
30mg |
26.3mg |
-12.4% |
96.23% |
Lab B |
| 21 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
4.3 |
10g |
12.4g |
+24.0% |
99.94% |
Lab E |
| 21 May 2026 |
Proviron (Mesterolone) |
9.4 |
10mg |
9.2mg |
-7.5% |
97.64% |
Lab D |
| 21 May 2026 |
S-23 Raw |
7.9 |
500g |
505.2g |
+1.0% |
96.46% |
Lab D |
| 21 May 2026 |
Trenbolone Acetate Raw |
6.4 |
5g |
5.2g |
+3.7% |
98.58% |
Lab F |
| 21 May 2026 |
Arimidex (Anastrozole) |
8.9 |
100mg |
88.3mg |
-11.7% |
98.22% |
Lab F |
| 21 May 2026 |
Clenbuterol |
4.9 |
50mg |
50.3mg |
+0.6% |
98.65% |
Lab F |
| 21 May 2026 |
HCG |
8.1 |
30mg |
33.7mg |
+12.3% |
97.70% |
Lab D |
| 21 May 2026 |
Lipo-B 216mg |
9.3 |
250mg/ml |
248.4mg/ml |
-0.6% |
99.15% |
Lab C |
| 21 May 2026 |
PEG MGF |
7.5 |
20mg |
18.5mg |
-7.5% |
96.24% |
Lab F |
| 21 May 2026 |
Proviron (Mesterolone) |
8.4 |
20mg |
19.5mg |
-2.5% |
96.59% |
Lab C |
| 21 May 2026 |
Trenbolone Acetate Raw |
4.5 |
100g |
106.0g |
+6.0% |
97.54% |
Lab E |
| 21 May 2026 |
Trenbolone Acetate Raw |
7.2 |
500g |
485.2g |
-3.0% |
97.47% |
Lab D |
| 20 May 2026 |
17a-Methyl-1-Testosterone |
4.0 |
50mg |
57.0mg |
+14.0% |
97.48% |
Lab C |
| 20 May 2026 |
BAM15 |
5.0 |
100mg |
92.8mg |
-7.2% |
99.70% |
Lab E |
| 20 May 2026 |
BAM15 |
4.8 |
100mg |
95.1mg |
-4.9% |
98.48% |
Lab C |
| 20 May 2026 |
BPC-157 Arg Oral |
5.5 |
25mg |
22.7mg |
-9.2% |
98.41% |
Lab D |
| 20 May 2026 |
Dermorphin |
8.5 |
10mg |
8.7mg |
-13.2% |
99.90% |
Lab E |
| 20 May 2026 |
LGD-4033 (Ligandrol) Raw |
6.2 |
100g |
87.4g |
-12.6% |
99.86% |
Lab C |
| 20 May 2026 |
Minoxidil Oral |
7.3 |
50mg |
59.6mg |
+19.3% |
96.58% |
Lab A |
| 20 May 2026 |
MOTS-C |
8.7 |
5mg |
5.7mg |
+14.7% |
99.96% |
Lab D |
| 20 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.7 |
50mg |
51.7mg |
+3.4% |
98.58% |
Lab F |
| 20 May 2026 |
Ostarine (MK-2866) |
9.7 |
10mg |
11.3mg |
+13.1% |
95.27% |
Lab E |
| 19 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.3 |
30mg |
28.0mg |
-6.5% |
99.03% |
Lab D |
| 19 May 2026 |
Clenbuterol |
6.7 |
100mg |
121.0mg |
+21.0% |
96.74% |
Lab E |
| 19 May 2026 |
Estradiol Cypionate |
6.4 |
100mg/ml |
95.7mg/ml |
-4.3% |
98.83% |
Lab F |
| 19 May 2026 |
HCG |
6.0 |
10mg |
10.7mg |
+7.0% |
96.59% |
Lab G |
| 19 May 2026 |
Lipo-B 216mg |
6.1 |
100mg/ml |
86.3mg/ml |
-13.7% |
97.20% |
Lab D |
| 19 May 2026 |
PEG MGF |
6.7 |
15mg |
14.5mg |
-3.1% |
98.84% |
Lab F |
| 19 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
8.8 |
1g |
1.1g |
+9.1% |
98.77% |
Lab G |
| 19 May 2026 |
Proviron (Mesterolone) |
8.2 |
25mg |
25.7mg |
+2.9% |
98.92% |
Lab F |
| 19 May 2026 |
PTD-DBM |
5.8 |
5mg |
5.2mg |
+3.2% |
99.93% |
Lab D |
| 19 May 2026 |
T3 (Liothyronine) |
6.3 |
20mg |
24.8mg |
+24.1% |
98.68% |
Lab G |
| 19 May 2026 |
Trenbolone Acetate Raw |
5.4 |
1g |
0.9g |
-7.1% |
97.14% |
Lab B |
| 17 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
5.0 |
2mg |
2.2mg |
+10.3% |
97.67% |
Lab B |
| 17 May 2026 |
Estradiol Cypionate |
5.6 |
300mg/ml |
317.4mg/ml |
+5.8% |
95.92% |
Lab B |
| 17 May 2026 |
HCG |
5.8 |
15mg |
15.6mg |
+3.9% |
96.57% |
Lab A |
| 17 May 2026 |
MGF |
7.2 |
15mg |
17.9mg |
+19.7% |
96.35% |
Lab A |
| 17 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
8.2 |
2mg |
2.3mg |
+16.1% |
96.42% |
Lab E |
| 17 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.9 |
50mg |
46.0mg |
-8.1% |
95.67% |
Lab B |
| 17 May 2026 |
Ostarine (MK-2866) |
6.9 |
25mg |
22.8mg |
-8.8% |
97.21% |
Lab E |
| 17 May 2026 |
PE 22-28 |
7.9 |
50mg |
57.8mg |
+15.5% |
96.29% |
Lab A |
| 17 May 2026 |
PEG MGF |
6.4 |
15mg |
16.7mg |
+11.4% |
98.31% |
Lab G |
| 17 May 2026 |
T3 (Liothyronine) |
7.2 |
50mg |
45.6mg |
-8.8% |
95.00% |
Lab D |
| 29 Jan 2026 |
Dermorphin |
7.6 |
10mg |
11.3mg |
+13.1% |
95.97% |
Lab D |
| 29 Jan 2026 |
Dianabol Raw |
6.2 |
5g |
4.8g |
-4.1% |
95.19% |
Lab F |
| 29 Jan 2026 |
LGD-4033 (Ligandrol) Raw |
8.2 |
500g |
579.2g |
+15.8% |
97.30% |
Lab B |
| 29 Jan 2026 |
MGF |
4.8 |
50mg |
52.7mg |
+5.5% |
97.35% |
Lab E |
| 29 Jan 2026 |
MGF |
5.7 |
10mg |
12.2mg |
+21.7% |
95.04% |
Lab A |
| 29 Jan 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
5.3 |
50mg |
45.7mg |
-8.5% |
97.57% |
Lab D |
| 29 Jan 2026 |
PE 22-28 |
8.5 |
50mg |
43.4mg |
-13.3% |
95.80% |
Lab D |
| 29 Jan 2026 |
Trenbolone Acetate Raw |
7.6 |
100g |
109.3g |
+9.3% |
95.07% |
Lab G |
| 26 Jan 2026 |
BAM15 |
7.1 |
100mg |
90.9mg |
-9.1% |
98.92% |
Lab F |
| 26 Jan 2026 |
BPC-157 Arg Oral |
5.8 |
10mg |
9.0mg |
-9.6% |
99.80% |
Lab D |
| 26 Jan 2026 |
Estradiol Cypionate |
8.7 |
200mg/ml |
235.0mg/ml |
+17.5% |
97.67% |
Lab E |
| 26 Jan 2026 |
Estradiol Cypionate |
6.1 |
100mg/ml |
85.2mg/ml |
-14.8% |
96.90% |
Lab B |
| 26 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.4 |
10mg |
9.9mg |
-1.3% |
97.27% |
Lab D |
| 26 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
7.2 |
50mg |
54.4mg |
+8.7% |
98.71% |
Lab G |
| 26 Jan 2026 |
PEG MGF |
8.4 |
15mg |
14.4mg |
-4.2% |
97.09% |
Lab A |
| 26 Jan 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.0 |
10g |
9.8g |
-2.0% |
97.30% |
Lab B |
| 26 Jan 2026 |
Proviron (Mesterolone) |
8.7 |
25mg |
28.1mg |
+12.2% |
96.51% |
Lab E |
| 26 Jan 2026 |
T3 (Liothyronine) |
7.7 |
25mg |
24.2mg |
-3.0% |
97.67% |
Lab D |
| 26 Jan 2026 |
T3 (Liothyronine) |
7.5 |
50mg |
54.5mg |
+8.9% |
99.08% |
Lab D |
| 19 Jan 2026 |
17a-Methyl-1-Testosterone |
6.9 |
100mg |
121.1mg |
+21.1% |
99.56% |
Lab B |
| 19 Jan 2026 |
17a-Methyl-1-Testosterone |
8.0 |
20mg |
22.7mg |
+13.6% |
99.14% |
Lab F |
| 19 Jan 2026 |
BAM15 |
7.7 |
10mg |
9.0mg |
-10.2% |
98.14% |
Lab B |
| 19 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
8.1 |
5mg |
6.2mg |
+23.9% |
96.97% |
Lab F |
| 19 Jan 2026 |
HCG |
8.3 |
20mg |
19.4mg |
-2.8% |
95.09% |
Lab A |
| 19 Jan 2026 |
Trenbolone Acetate Raw |
7.1 |
10g |
10.2g |
+2.3% |
97.37% |
Lab C |
| 9 Jan 2026 |
17a-Methyl-1-Testosterone |
7.5 |
25mg |
27.6mg |
+10.2% |
99.24% |
Lab E |
| 9 Jan 2026 |
Anadrol Oil |
4.8 |
300mg/ml |
319.0mg/ml |
+6.3% |
95.74% |
Lab D |
| 9 Jan 2026 |
Dianabol Raw |
7.2 |
100g |
122.4g |
+22.4% |
98.31% |
Lab B |
| 9 Jan 2026 |
DSIP |
7.8 |
30mg |
37.2mg |
+24.0% |
98.07% |
Lab G |
| 9 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
7.2 |
5mg |
5.2mg |
+3.1% |
97.26% |
Lab D |
| 9 Jan 2026 |
N-Acetyl Epitalon Amidate |
7.3 |
30mg |
30.6mg |
+2.0% |
99.51% |
Lab F |
| 9 Jan 2026 |
Ostarine (MK-2866) |
8.0 |
20mg |
20.2mg |
+1.2% |
99.16% |
Lab E |
| 9 Jan 2026 |
Proviron (Mesterolone) |
8.4 |
25mg |
21.3mg |
-14.9% |
97.02% |
Lab C |
| 9 Jan 2026 |
T3 (Liothyronine) |
6.8 |
10mg |
10.3mg |
+2.7% |
98.65% |
Lab F |
| 9 Jan 2026 |
Trenbolone Acetate Raw |
7.7 |
5g |
5.9g |
+18.5% |
99.37% |
Lab G |
| 7 Jan 2026 |
17a-Methyl-1-Testosterone |
4.6 |
100mg |
93.9mg |
-6.1% |
99.05% |
Lab C |
| 7 Jan 2026 |
HCG |
5.9 |
15mg |
17.5mg |
+16.7% |
97.24% |
Lab B |
| 7 Jan 2026 |
Lipo-B 216mg |
8.0 |
100mg/ml |
107.7mg/ml |
+7.7% |
97.29% |
Lab F |
| 7 Jan 2026 |
Ostarine (MK-2866) |
8.9 |
10mg |
11.8mg |
+18.1% |
95.47% |
Lab A |
| 7 Jan 2026 |
SNAP-8 |
7.2 |
50mg |
58.3mg |
+16.7% |
99.29% |
Lab G |
| 7 Jan 2026 |
Trenbolone Acetate Raw |
4.8 |
5g |
5.9g |
+18.3% |
99.82% |
Lab D |
| 6 Jan 2026 |
N-Acetyl Epitalon Amidate |
6.1 |
50mg |
50.4mg |
+0.9% |
98.54% |
Lab C |
| 6 Jan 2026 |
Ostarine (MK-2866) |
5.9 |
20mg |
18.3mg |
-8.4% |
99.98% |
Lab B |
| 6 Jan 2026 |
Ostarine (MK-2866) |
6.8 |
25mg |
29.4mg |
+17.8% |
95.25% |
Lab E |
| 6 Jan 2026 |
P21 |
8.0 |
30mg |
34.3mg |
+14.3% |
96.54% |
Lab G |
| 6 Jan 2026 |
P21 |
8.7 |
10mg |
11.9mg |
+18.6% |
99.46% |
Lab F |
| 6 Jan 2026 |
PE 22-28 |
6.6 |
2mg |
1.8mg |
-9.2% |
97.13% |
Lab D |
| 6 Jan 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
6.1 |
5g |
5.6g |
+11.5% |
97.02% |
Lab E |
| 6 Jan 2026 |
Proviron (Mesterolone) |
7.3 |
25mg |
22.0mg |
-12.2% |
95.47% |
Lab C |
| 6 Jan 2026 |
T3 (Liothyronine) |
8.0 |
20mg |
18.7mg |
-6.3% |
99.46% |
Lab F |
| 29 Dec 2025 |
BPC-157 Arg Oral |
6.3 |
50mg |
45.2mg |
-9.7% |
95.41% |
Lab D |
| 29 Dec 2025 |
BPC-157 Arg Oral |
6.9 |
25mg |
27.2mg |
+8.7% |
97.47% |
Lab G |
| 29 Dec 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
6.0 |
30mg |
36.8mg |
+22.7% |
97.82% |
Lab E |
| 29 Dec 2025 |
Clenbuterol |
7.4 |
50mg |
62.2mg |
+24.4% |
98.32% |
Lab A |
| 29 Dec 2025 |
Dermorphin |
4.9 |
5mg |
5.1mg |
+2.2% |
98.57% |
Lab C |
| 29 Dec 2025 |
LGD-4033 (Ligandrol) Raw |
6.5 |
10g |
10.1g |
+0.6% |
99.94% |
Lab B |
| 29 Dec 2025 |
Livagen |
5.9 |
50mg |
56.6mg |
+13.2% |
98.29% |
Lab D |
| 29 Dec 2025 |
MGF |
6.8 |
15mg |
16.6mg |
+10.9% |
97.54% |
Lab F |
| 29 Dec 2025 |
P21 |
8.6 |
15mg |
16.0mg |
+6.5% |
97.46% |
Lab F |
| 29 Dec 2025 |
Proviron (Mesterolone) |
7.1 |
50mg |
51.5mg |
+3.1% |
95.46% |
Lab C |
| 29 Dec 2025 |
T3 (Liothyronine) |
5.0 |
100mg |
97.6mg |
-2.4% |
98.59% |
Lab B |
| 12 Dec 2025 |
17a-Methyl-1-Testosterone |
8.7 |
20mg |
20.6mg |
+3.0% |
97.91% |
Lab A |
| 12 Dec 2025 |
Anadrol Oil |
5.2 |
300mg/ml |
372.4mg/ml |
+24.1% |
95.75% |
Lab E |
| 12 Dec 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.9 |
10mg |
10.1mg |
+0.8% |
96.68% |
Lab E |
| 12 Dec 2025 |
Lipo-B 216mg |
7.9 |
200mg/ml |
192.5mg/ml |
-3.8% |
96.87% |
Lab D |
| 12 Dec 2025 |
Methylstenbolone |
8.2 |
10mg |
11.9mg |
+19.4% |
96.91% |
Lab E |
| 12 Dec 2025 |
MOTS-C |
8.0 |
30mg |
27.9mg |
-7.1% |
95.67% |
Lab B |
| 12 Dec 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.8 |
20mg |
20.7mg |
+3.3% |
97.43% |
Lab B |
| 12 Dec 2025 |
PEG MGF |
6.0 |
10mg |
10.0mg |
-0.2% |
95.81% |
Lab G |
| 12 Dec 2025 |
SNAP-8 |
7.1 |
2mg |
1.9mg |
-7.1% |
96.57% |
Lab C |
| 5 Dec 2025 |
17a-Methyl-1-Testosterone |
7.1 |
50mg |
58.5mg |
+16.9% |
98.37% |
Lab D |
| 5 Dec 2025 |
BAM15 |
8.0 |
100mg |
119.8mg |
+19.8% |
99.68% |
Lab C |
| 5 Dec 2025 |
Clenbuterol |
6.0 |
50mg |
62.3mg |
+24.5% |
97.61% |
Lab F |
| 5 Dec 2025 |
Estradiol Cypionate |
8.0 |
100mg/ml |
119.2mg/ml |
+19.2% |
97.07% |
Lab D |
| 5 Dec 2025 |
LGD-4033 (Ligandrol) Raw |
7.7 |
1g |
1.1g |
+11.0% |
96.28% |
Lab A |
| 5 Dec 2025 |
Methylstenbolone |
5.9 |
50mg |
46.3mg |
-7.4% |
95.14% |
Lab E |
| 5 Dec 2025 |
Methylstenbolone |
9.3 |
10mg |
8.8mg |
-11.8% |
98.49% |
Lab F |
| 5 Dec 2025 |
P21 |
7.8 |
2mg |
2.2mg |
+9.6% |
97.93% |
Lab F |
| 5 Dec 2025 |
PE 22-28 |
7.5 |
2mg |
1.9mg |
-6.1% |
99.31% |
Lab E |
| 5 Dec 2025 |
PTD-DBM |
6.4 |
15mg |
13.8mg |
-8.0% |
99.49% |
Lab C |
| 5 Dec 2025 |
SNAP-8 |
9.4 |
2mg |
1.7mg |
-14.0% |
97.78% |
Lab B |
| 5 Dec 2025 |
Tirzepatide 30mg Pen Kit |
6.5 |
30mg |
32.4mg |
+8.0% |
99.53% |
Lab A |
| 23 Nov 2025 |
17a-Methyl-1-Testosterone |
6.3 |
20mg |
17.6mg |
-11.9% |
99.22% |
Lab G |
| 23 Nov 2025 |
Dermorphin |
6.9 |
50mg |
48.2mg |
-3.7% |
95.78% |
Lab A |
| 23 Nov 2025 |
DSIP |
8.9 |
30mg |
29.5mg |
-1.5% |
96.02% |
Lab A |
| 23 Nov 2025 |
Lipo-B 216mg |
8.2 |
300mg/ml |
362.5mg/ml |
+20.8% |
95.20% |
Lab D |
| 23 Nov 2025 |
Proviron (Mesterolone) |
7.5 |
50mg |
49.2mg |
-1.5% |
97.99% |
Lab E |
| 23 Nov 2025 |
T3 (Liothyronine) |
7.4 |
10mg |
10.4mg |
+3.8% |
99.82% |
Lab B |
| 17 Nov 2025 |
17a-Methyl-1-Testosterone |
7.7 |
20mg |
19.2mg |
-3.9% |
95.40% |
Lab D |
| 17 Nov 2025 |
Dermorphin |
7.1 |
50mg |
52.4mg |
+4.8% |
96.53% |
Lab B |
| 17 Nov 2025 |
HCG |
6.3 |
10mg |
11.9mg |
+18.5% |
95.08% |
Lab C |
| 17 Nov 2025 |
P21 |
8.5 |
2mg |
2.2mg |
+12.1% |
95.68% |
Lab F |
| 17 Nov 2025 |
PE 22-28 |
6.3 |
5mg |
5.9mg |
+18.4% |
99.30% |
Lab F |
| 17 Nov 2025 |
S-23 Raw |
5.4 |
10g |
9.7g |
-2.7% |
97.12% |
Lab C |
| 17 Nov 2025 |
SNAP-8 |
6.6 |
30mg |
33.8mg |
+12.8% |
95.45% |
Lab E |
| 14 Nov 2025 |
BAM15 |
6.5 |
50mg |
54.8mg |
+9.5% |
97.47% |
Lab B |
| 14 Nov 2025 |
BAM15 |
4.5 |
50mg |
47.2mg |
-5.6% |
95.83% |
Lab D |
| 14 Nov 2025 |
Clenbuterol |
6.6 |
25mg |
21.9mg |
-12.2% |
96.35% |
Lab F |
| 14 Nov 2025 |
Dianabol Raw |
6.2 |
5g |
5.6g |
+12.3% |
95.54% |
Lab A |
| 14 Nov 2025 |
DSIP |
6.7 |
15mg |
17.8mg |
+18.9% |
95.95% |
Lab D |
| 14 Nov 2025 |
Estradiol Cypionate |
8.5 |
100mg/ml |
99.3mg/ml |
-0.7% |
96.97% |
Lab D |
| 14 Nov 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
8.8 |
10mg |
9.1mg |
-8.6% |
95.36% |
Lab G |
| 14 Nov 2025 |
HCG |
7.3 |
5mg |
5.8mg |
+16.3% |
95.64% |
Lab C |
| 14 Nov 2025 |
LGD-4033 (Ligandrol) Raw |
7.6 |
10g |
9.6g |
-4.3% |
98.18% |
Lab A |
| 14 Nov 2025 |
Methylstenbolone |
8.1 |
10mg |
11.5mg |
+15.2% |
99.24% |
Lab D |
| 14 Nov 2025 |
Minoxidil Oral |
6.9 |
20mg |
19.7mg |
-1.6% |
96.81% |
Lab F |
| 14 Nov 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.9 |
30mg |
25.5mg |
-14.9% |
99.39% |
Lab E |
| 14 Nov 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
5.1 |
5g |
4.3g |
-14.5% |
95.18% |
Lab D |
| 14 Nov 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
8.7 |
5g |
5.9g |
+17.6% |
97.54% |
Lab B |
| 14 Nov 2025 |
T3 (Liothyronine) |
6.2 |
10mg |
10.8mg |
+8.1% |
97.25% |
Lab C |
| 14 Nov 2025 |
Tirzepatide 30mg Pen Kit |
8.3 |
10mg |
10.0mg |
-0.2% |
99.85% |
Lab A |
| 14 Nov 2025 |
Trenbolone Acetate Raw |
7.0 |
5g |
5.7g |
+14.5% |
97.47% |
Lab E |
| 5 Nov 2025 |
17a-Methyl-1-Testosterone |
6.3 |
50mg |
43.5mg |
-12.9% |
97.51% |
Lab A |
| 5 Nov 2025 |
Arimidex (Anastrozole) |
8.3 |
25mg |
30.3mg |
+21.3% |
99.41% |
Lab B |
| 5 Nov 2025 |
BAM15 |
4.9 |
50mg |
56.7mg |
+13.3% |
98.58% |
Lab B |
| 5 Nov 2025 |
BPC-157 Arg Oral |
7.6 |
20mg |
21.6mg |
+8.2% |
96.39% |
Lab F |
| 5 Nov 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
4.9 |
1g |
1.1g |
+9.2% |
97.62% |
Lab D |
| 5 Nov 2025 |
T3 (Liothyronine) |
9.3 |
10mg |
11.5mg |
+14.7% |
95.40% |
Lab B |
| 5 Nov 2025 |
Tirzepatide 30mg Pen Kit |
6.5 |
50mg |
50.5mg |
+1.0% |
98.26% |
Lab A |
| 5 Nov 2025 |
Trenbolone Acetate Raw |
5.3 |
10g |
9.2g |
-8.5% |
99.46% |
Lab F |
| 4 Nov 2025 |
Anadrol Oil |
6.1 |
200mg/ml |
226.1mg/ml |
+13.0% |
97.16% |
Lab A |
| 4 Nov 2025 |
Clenbuterol |
7.4 |
100mg |
85.6mg |
-14.4% |
99.03% |
Lab A |
| 4 Nov 2025 |
MOTS-C |
7.4 |
50mg |
46.6mg |
-6.7% |
95.90% |
Lab C |
| 4 Nov 2025 |
Ostarine (MK-2866) |
5.3 |
50mg |
58.0mg |
+16.0% |
99.55% |
Lab B |
| 4 Nov 2025 |
PEG MGF |
6.7 |
10mg |
8.8mg |
-12.3% |
97.18% |
Lab F |
| 17 Oct 2025 |
AOD9604 |
5.6 |
20mg |
19.0mg |
-4.8% |
95.64% |
Lab E |
| 17 Oct 2025 |
HCG |
8.7 |
15mg |
15.0mg |
-0.0% |
97.53% |
Lab E |
| 17 Oct 2025 |
Minoxidil Oral |
7.9 |
50mg |
58.6mg |
+17.2% |
96.82% |
Lab A |
| 17 Oct 2025 |
Minoxidil Oral |
7.2 |
20mg |
23.3mg |
+16.7% |
96.45% |
Lab A |
| 17 Oct 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
5.3 |
500g |
506.8g |
+1.4% |
97.58% |
Lab E |
| 17 Oct 2025 |
T3 (Liothyronine) |
8.3 |
100mg |
104.1mg |
+4.1% |
99.09% |
Lab A |
| 17 Oct 2025 |
T3 (Liothyronine) |
7.1 |
20mg |
20.1mg |
+0.3% |
95.95% |
Lab C |
| 17 Oct 2025 |
Trenbolone Acetate Raw |
8.9 |
1g |
1.1g |
+5.2% |
95.72% |
Lab E |
| 9 Oct 2025 |
BPC-157 Arg Oral |
5.2 |
100mg |
119.9mg |
+19.9% |
99.37% |
Lab A |
| 9 Oct 2025 |
Clenbuterol |
7.3 |
25mg |
27.1mg |
+8.2% |
99.55% |
Lab B |
| 9 Oct 2025 |
Clenbuterol |
6.7 |
100mg |
96.8mg |
-3.2% |
99.77% |
Lab A |
| 9 Oct 2025 |
Dianabol Raw |
8.6 |
10g |
10.3g |
+3.1% |
96.28% |
Lab C |
| 9 Oct 2025 |
P21 |
6.7 |
2mg |
1.9mg |
-4.3% |
95.30% |
Lab E |
| 3 Oct 2025 |
AOD9604 |
6.3 |
30mg |
28.7mg |
-4.4% |
96.52% |
Lab G |
| 3 Oct 2025 |
BPC-157 Arg Oral |
6.6 |
50mg |
42.7mg |
-14.6% |
98.27% |
Lab B |
| 3 Oct 2025 |
BPC-157 Arg Oral |
9.6 |
25mg |
30.8mg |
+23.1% |
96.27% |
Lab G |
| 3 Oct 2025 |
Clenbuterol |
5.4 |
100mg |
100.5mg |
+0.5% |
95.75% |
Lab A |
| 3 Oct 2025 |
Estradiol Cypionate |
7.3 |
100mg/ml |
88.0mg/ml |
-12.0% |
95.69% |
Lab F |
| 3 Oct 2025 |
LGD-4033 (Ligandrol) Raw |
5.6 |
1g |
1.1g |
+10.0% |
96.05% |
Lab G |
| 3 Oct 2025 |
P21 |
7.0 |
10mg |
12.3mg |
+22.7% |
99.30% |
Lab A |
| 3 Oct 2025 |
PE 22-28 |
5.3 |
50mg |
56.4mg |
+12.7% |
97.24% |
Lab E |
| 3 Oct 2025 |
T3 (Liothyronine) |
5.1 |
100mg |
91.1mg |
-8.9% |
95.02% |
Lab C |